Antagonist Antibodies to PD-1 and B7-H1 (PD-L1) in the Treatment of Advanced Human Cancer - Letter

Eitemau Tebyg

• Immediate triggering of 4-1BB co-stimulation during initiation of tumor-infiltrating lymphocyte (TIL) expansion from melanoma tumors accelerates CD8+ T-cell outgrowth and tumor specificity
  gan: Chacon, Jessica, et al.
  Cyhoeddwyd: (2013)
• Continuous 4–1BB co-stimulatory signals for the optimal expansion of tumor-infiltrating lymphocytes for adoptive T-cell therapy
  gan: Chacon, Jessica Ann, et al.
  Cyhoeddwyd: (2013)
• Antagonist Antibodies to PD-1 and B7-H1 (PD-L1) in the Treatment of Advanced Human Cancer
  gan: Sznol, Mario, et al.
  Cyhoeddwyd: (2013)
• Antagonist Antibodies to PD-1 and B7-H1 (PD-L1) in the Treatment of Advanced Human Cancer
  gan: Sznol, Mario, et al.
  Cyhoeddwyd: (2013)
• Triggering co-stimulation directly in melanoma tumor fragments drives CD8(+) tumor-infiltrating lymphocyte expansion with improved effector-memory properties
  gan: Chacon, Jessica Ann, et al.
  Cyhoeddwyd: (2015)